http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Ha, U‐,Syn,Kim, Sung In,Kim, Su Jin,Cho, Hyuk‐,Jin,Hong, Sung‐,Hoo,Lee, Ji Youl,Kim, Joon Chul,Kim, Sae Woong,Hwang, Tae‐,Kon Blackwell Publishing Asia 2010 International journal of urology Vol.17 No.1
<P><B>Objective: </B> To compare the mid‐term oncological outcome of laparoscopic radical cystectomy (LRC) with those of open radical cystectomy (ORC).</P><P><B>Methods: </B> From June 2003 to February 2008, 36 LRCs were carried out at our institute for the treatment of bladder cancer. Clinical and oncological data were retrospectively analyzed. A match‐pair comparison with an historical series of 34 patients who were submitted to ORC between 1996 and 2003 was carried out.</P><P><B>Results: </B> Median follow‐up of the LRC group was 21 months (3–56 months). Pathological stage or grade was similar in the two groups. There was no significant difference between the LRC and ORC groups in terms of 3‐year overall (64.2% <I>vs</I> 72.6%, respectively; <I>P</I> = 0.682), cancer‐specific (73.0% <I>vs</I> 75.3%, respectively; <I>P</I> = 0.951), and recurrence‐free survival (70.5% <I>vs</I> 72.5%, respectively; <I>P</I> = 0.715) rates. In a subgroup analysis according to stage, there was also no significant difference in the 3‐year disease‐specific survival after LRC or ORC for organ‐confined (pT1 and pT2; 85.7% <I>vs</I> 83.9%, respectively; <I>P</I> = 0.256) or extravesical disease (pT3 and pT4; 73.3% <I>vs</I> 63.8%, respectively; <I>P</I> = 0.825).</P><P><B>Conclusion: </B> These findings suggest that LRC provides mid‐term oncological outcomes similar to those of ORC in the management of bladder cancer.</P>
급성 단순성 방광염의 경험적 치료로써 Cefcapene Pivoxil의 유효성
이승주,하유신,김현우,조용현 대한감염학회 2008 감염과 화학요법 Vol.40 No.3
목적 : 급성 단순성 방광염은 일반적으로 원인균에 대한 그 지역의 항생제 내성조사가 이루어지고 그 결과에 따라 항생제가 경험적으로 처방된다. 하지만 최근 우리나라에서 fluoroquinolone계 항생제에 대한 요로감염 원인균의 내성 증가가 보고되고 있어 그 동안 경험적 1차치료제로 선택되었던 fluoroquinolone계 항생제의 역할에 한계가 보이고 있는 실정이다. 이에 저자들은 급성 단순성 방광염 환자에서 cefcapene pivoxil의 미생물학적, 임상적 유효성 및 안전성을 알아보고자 하였다. 재료 및 방법 : 시험은 전향적, 비맹검, 공개, 비비교 임상시험으로 시행되었고 서울지역 2개 종합병원을 방문한 92명의 급성 단순성 방광염 환자에게 cefcapene pivoxil 100 mg을 1일 3회, 5일간 경구 투여하여 1-3일과 2주 후에 추적 관찰하였다. 결과 : 평가가 가능하였던 77명의 환자 중 75명의 환자에서 치료완료 2주 후에 원인균이 제거되어 97.4%의 미생물학적 유효성을 보였으며, 74명의 환자에서 치료 후 증상이 소실되었거나 호전되어 96.1%의 임상적 유효성을 보였다. 약물 관련 이상반응은 8명의 환자에서 나타났으나 이로 인한 치료 중단 사례는 없었으며, 심각한 생화학적 또는 혈액학적 이상반응은 나타나지 않았다. 결론 : Cefcapene 100 mg 1일 3회 5일요법은 미생물학적, 임상적 유효성이 뛰어나며 안전한 치료요법으로 급성단순성 방광염의 경험적 항생제 치료에 적합할 것으로 생각된다. Background : A high prevalence of fluoroquinolone resistance among uropathogens has been observed in Korea. Since empirical antimicrobial therapy should be guided by the proportion of pathogens resistant to the chosen antibiotic, the limitation of fluoroquinolones as the first empirical choice for acute cystitis is noticed in the clinical setting. The present study was undertaken to determine the susceptibility profiles of urinary isolates to cefcapene pivoxil and assess the clinical efficacy in patients with acute uncomplicated cystitis. Materials and Methods : The study was a prospective, open label, non-comparative, non-blinded trial. Ninety-two patients with acute, uncomplicated symptomatic cystitis from two hospitals were treated with cefcapene pivoxil 100 mg tid for 5 days and followed up for 2 weeks. Results : Seventy-seven of the 92 patients were evaluated. Bacteriological eradication of initial pathogens was achieved in 97.4% by 2 weeks after therapy termination. Seventy-four of 77 (96.1%) patients were symptomatically cured or improved after completion of therapy. Drug related adverse experiences were seen in 8 patients. None necessitated cessation of therapy. No Significant biochemical or hematological abnormalities occurred. Conclusion : These results demonstrate the clinical efficacy and safety of empirical 5-day cefcapene pivoxil for acute uncomplicated cystitis.
만삭 자궁근세포에서 염증성 사이토카인에 의한 nuclear factor-kappa B 활성화 양상의 진통 유무에 따른 차이 비교
양순하 ( Soon Ha Yang ),신희철 ( Hee Chul Syn ) 대한산부인과학회 2005 Obstetrics & Gynecology Science Vol.48 No.3
Objective: The objectives of this study were to determine whether NF-κB-mediated pro-inflammatory cytokines signaling leads to COX-2 expression and PGE2 synthesis in human myometrial cells at term, and to compare cytokines-induced NF-κB activity and subse
Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats
Woong Jin Bae,U Syn Ha,Jin Bong Choi,Kang Sup Kim,Su Jin Kim,Hyuk Jin Cho,Sung Hoo Hong,Ji Youl Lee,Zhiping Wang,Sung Yeoun Hwang,Sae Woong Kim 대한남성과학회 2015 The World Journal of Men's Health Vol.33 No.2
Purpose: We investigated the protective effects of the herbal formulation KH-204 in the bladder of androgen-deprived rats. Materials and Methods: Male rats aged eight weeks were randomly divided into four groups, containing eight rats each: sham operation only (normal control group), androgen-deprived only (androgen-deprived control group), and androgen-deprived followed by treatment with 200 mg/kg or 400 mg/kg of KH-204. After 0.5 mg/kg of leuprorelin was subcutaneously injected in the androgen-deprived groups, the oral administration of either distilled water in the two control groups or KH-204 in the treatment group was continued for four weeks. Serum testosterone levels, RhoGEF levels, nitric oxide (NO)-cyclic guanosine monophosphate (cGMP)-related parameters, oxidative stress, and histologic changes were evaluated after treatment. Results: Treatment with the herbal formulation KH-204 (1) increased serum testosterone levels; (2) restored the expression of RhoGEFs, endothelial NO synthase, and neuronal NO synthase; (3) increased the expression of superoxide dismutase; and (4) decreased bladder fibrosis. Conclusions: Our results suggest that the positive effects of KH-204 on the urinary bladder may be attributed to its antioxidant effects or to an elevation in NO-cGMP activity.